Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Prothena reported $741.59M in Assets for its fiscal quarter ending in March of 2023.

Assets Change
Acadia Pharmaceuticals ACAD:US USD 655.3M 67.49M
Agios Pharmaceuticals AGIO:US USD 1.15B 87.42M
Akebia Therapeutics AKBA:US USD 276.86M 74.97M
Alnylam Pharmaceuticals ALNY:US USD 3.39B 154.42M
Amgen AMGN:US USD 88.72B 23.6B
Biogen BIIB:US USD 24.6B 44.3M
BioMarin Pharmaceutical BMRN:US USD 6.43B 58.62M
Bluebird Bio BLUE:US USD 692.74M 137.83M
Exelixis EXEL:US USD 3.14B 71.87M
Immunic Inc. VTL:US USD 108.87M 18.88M
Incyte Corp INCY:US USD 5.8B 43.36M
Intercept Pharmaceuticals ICPT:US USD 504.08M 49.63M
Intra Cellular Therapies ITCI:US USD 722.16M 32.62M
Ionis Pharmaceuticals IONS:US USD 2.89B 351.34M
MacroGenics MGNX:US USD 343.5M 63.03M
Nektar Therapeutics NKTR:US USD 561.74M 148.86M
Neurocrine Biosciences NBIX:US USD 2.36B 8.9M
Prothena PRTA:US USD 741.59M 16.45M
Regeneron Pharmaceuticals REGN:US USD 30.06B 845.4M
Seattle Genetics SGEN:US USD 3.54B 131.24M
Ultragenyx Pharmaceutical RARE:US USD 1.38B 162.04M
Vertex Pharmaceuticals VRTX:US USD 18.97B 823.3M